‘UltraSight’ is revolutionizing cardiac ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The ‘UltraSight’ AI guidance software helps to bring the benefits of cardiac imaging to more healthcare professionals in new care settings and increase patient access to advanced medical care.

‘UltraSight’ has won the TCT 2020 Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics, the world’s educational meeting specializing in interventional cardiovascular medicine.

Previously known as ‘OnSight Medical’, the company has changed its name to UltraSight.